Insulin dosing guidance to optimise type 2 diabetes management – Authors' reply
- 1 October 2019
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 394 (10206), 1321
- https://doi.org/10.1016/s0140-6736(19)31895-1
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Temporary Reductions in Insulin Requirements Are Associated with Hypoglycemia in Type 2 DiabetesDiabetes Technology & Therapeutics, 2018
- Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012Diabetes Care, 2015
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)Diabetes Care, 2014
- Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery deviceClinicoEconomics and Outcomes Research, 2013
- Adjust to Target in Type 2 DiabetesDiabetes Care, 2008